Log In
Print this Print this

AB-CD01 (formerly Ampliphage-004)

  Manage Alerts
Collapse Summary General Information
Company AmpliPhi Biosciences Corp.
DescriptionLytic bacteriophages against Clostridium difficile
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationClostridium
Indication DetailsTreat Clostridium difficile infection (CDI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today